282 related articles for article (PubMed ID: 19789350)
1. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model.
Helzer KT; Barnes HE; Day L; Harvey J; Billings PR; Forsyth A
Cancer Res; 2009 Oct; 69(19):7860-6. PubMed ID: 19789350
[TBL] [Abstract][Full Text] [Related]
2. Global gene expression profiling of circulating tumor cells.
Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
[TBL] [Abstract][Full Text] [Related]
3. Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.
Paris PL; Kobayashi Y; Zhao Q; Zeng W; Sridharan S; Fan T; Adler HL; Yera ER; Zarrabi MH; Zucker S; Simko J; Chen WT; Rosenberg J
Cancer Lett; 2009 May; 277(2):164-73. PubMed ID: 19162393
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells in solid tumor in metastatic and localized stages.
Maestro LM; Sastre J; Rafael SB; Veganzones SB; Vidaurreta M; Martín M; Olivier C; DE La Orden VB; Garcia-Saenz JA; Alfonso R; Arroyo M; Diaz-Rubio E
Anticancer Res; 2009 Nov; 29(11):4839-43. PubMed ID: 20032444
[TBL] [Abstract][Full Text] [Related]
5. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.
Zheng S; Lin H; Liu JQ; Balic M; Datar R; Cote RJ; Tai YC
J Chromatogr A; 2007 Aug; 1162(2):154-61. PubMed ID: 17561026
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis of circulating tumor cells in prostate cancer patients.
Larson CJ; Moreno JG; Pienta KJ; Gross S; Repollet M; O'hara SM; Russell T; Terstappen LW
Cytometry A; 2004 Nov; 62(1):46-53. PubMed ID: 15472900
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer.
Shaffer DR; Leversha MA; Danila DC; Lin O; Gonzalez-Espinoza R; Gu B; Anand A; Smith K; Maslak P; Doyle GV; Terstappen LW; Lilja H; Heller G; Fleisher M; Scher HI
Clin Cancer Res; 2007 Apr; 13(7):2023-9. PubMed ID: 17404082
[TBL] [Abstract][Full Text] [Related]
8. Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models.
Glinskii AB; Smith BA; Jiang P; Li XM; Yang M; Hoffman RM; Glinsky GV
Cancer Res; 2003 Jul; 63(14):4239-43. PubMed ID: 12874032
[TBL] [Abstract][Full Text] [Related]
9. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
[TBL] [Abstract][Full Text] [Related]
10. Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumors.
Ali A; Furusato B; Ts'o PO; Lum ZP; Elsamanoudi S; Mohamed A; Srivastava S; Moul JW; Brassell SA; Sesterhenn IA; McLeod DG
Pathol Int; 2010 Oct; 60(10):667-72. PubMed ID: 20846264
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic microchip to assay 3D colony-growth potential of captured circulating tumor cells.
Bichsel CA; Gobaa S; Kobel S; Secondini C; Thalmann GN; Cecchini MG; Lutolf MP
Lab Chip; 2012 Jul; 12(13):2313-6. PubMed ID: 22565166
[TBL] [Abstract][Full Text] [Related]
12. Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation.
Resel Folkersma L; Olivier Gómez C; San José Manso L; Veganzones de Castro S; Galante Romo I; Vidaurreta Lázaro M; de la Orden GV; Arroyo Fernández M; Díaz Rubio E; Silmi Moyano A; Maestro de Las Casas MA
Arch Esp Urol; 2010; 63(1):23-31. PubMed ID: 20157216
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer.
Danila DC; Heller G; Gignac GA; Gonzalez-Espinoza R; Anand A; Tanaka E; Lilja H; Schwartz L; Larson S; Fleisher M; Scher HI
Clin Cancer Res; 2007 Dec; 13(23):7053-8. PubMed ID: 18056182
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells predict survival in patients with metastatic prostate cancer.
Moreno JG; Miller MC; Gross S; Allard WJ; Gomella LG; Terstappen LW
Urology; 2005 Apr; 65(4):713-8. PubMed ID: 15833514
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of metastasis of circulating human prostate cancer cells in the chick embryo by an extracellular matrix produced by foreskin fibroblasts in culture.
Menen R; Pinney E; Hassanein MK; Kolostova K; Bobek V; Suetsugu A; Zhang N; Bouvet M; Naughton GK; Hoffman RM
Anticancer Res; 2012 May; 32(5):1573-7. PubMed ID: 22593434
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cells: evolving evidence and future challenges.
Dotan E; Cohen SJ; Alpaugh KR; Meropol NJ
Oncologist; 2009 Nov; 14(11):1070-82. PubMed ID: 19897536
[TBL] [Abstract][Full Text] [Related]
17. Characterization of circulating tumor cells by fluorescence in situ hybridization.
Swennenhuis JF; Tibbe AG; Levink R; Sipkema RC; Terstappen LW
Cytometry A; 2009 Jun; 75(6):520-7. PubMed ID: 19291800
[TBL] [Abstract][Full Text] [Related]
18. Site-specific cytomorphology of disseminated PC-3 prostate cancer cells visualized in vivo with fluorescent proteins.
Bobek V; Hoffman RM; Kolostova K
Diagn Cytopathol; 2013 May; 41(5):413-7. PubMed ID: 22508666
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score.
Kolostova K; Broul M; Schraml J; Cegan M; Matkowski R; Fiutowski M; Bobek V
Anticancer Res; 2014 Jul; 34(7):3641-6. PubMed ID: 24982381
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers.
Hiraiwa K; Takeuchi H; Hasegawa H; Saikawa Y; Suda K; Ando T; Kumagai K; Irino T; Yoshikawa T; Matsuda S; Kitajima M; Kitagawa Y
Ann Surg Oncol; 2008 Nov; 15(11):3092-100. PubMed ID: 18766405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]